Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Contraception and Contraceptive Drugs

  Free Subscription


Articles published in Life Sci

Retrieve available abstracts of 6 articles:
HTML format



Single Articles


    December 2020
  1. MIRDAMADI M, Kothencz A, Szucs E, Benyhe S, et al
    Non-genomic actions of sex hormones on pregnant uterine contractility in rats: An in vitro study at term.
    Life Sci. 2020;263:118584.
    PubMed     Abstract available


    September 2020
  2. KHAN S, Shukla S, Farhan M, Sinha S, et al
    Centchroman prevents metastatic colonization of breast cancer cells and disrupts angiogenesis via inhibition of RAC1/PAK1/beta-catenin signaling axis.
    Life Sci. 2020;256:117976.
    PubMed     Abstract available


    December 2019
  3. KAUSHIK S, Shyam H, Agarwal S, Sharma R, et al
    Genistein potentiates Centchroman induced antineoplasticity in breast cancer via PI3K/Akt deactivation and ROS dependent induction of apoptosis.
    Life Sci. 2019;239:117073.
    PubMed     Abstract available


    August 2018
  4. YASUDA K, Sumi GI, Murata H, Kida N, et al
    The steroid hormone dydrogesterone inhibits myometrial contraction independently of the progesterone/progesterone receptor pathway.
    Life Sci. 2018;207:508-515.
    PubMed     Abstract available


    February 2018
  5. SUN X, Deng X, Cai W, Li W, et al
    Icariin inhibits LPS-induced cell inflammatory response by promoting GRalpha nuclear translocation and upregulating GRalpha expression.
    Life Sci. 2018;195:33-43.
    PubMed     Abstract available


    January 2018
  6. DEWANGAN J, Kaushik S, Rath SK, Balapure AK, et al
    Centchroman regulates breast cancer angiogenesis via inhibition of HIF-1alpha/VEGFR2 signalling axis.
    Life Sci. 2018;193:9-19.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Contraception and Contraceptive Drugs is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: